TGDLF yields 6.21% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, TGDLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TGDLF + PFE for your $10,000?
Tongdao Liepin Group, an investment holding company, provides talent acquisition services in the People's Republic of China. The company operates Liepin, a talent acquisition platform, which offers online recruitment services for headhunters, business users, and individual users. It also operates Duomian, a video-based talent platform that allows job descriptions of business users and self-introductions of individual users in short video format; Xunhou, a staffing platform, which provides staffing SaaS solutions, such as human resource outsourcing, recruitment outsourcing, personnel agency, and campus recruitment; Lebanban, a training and assessment platform that offers employee learning and development solutions comprising training courses and employee performance evaluation; and Wenjuanxing, a survey SaaS platform, which provides data collection, storage, and analysis, as well as offers Liepin Campus, a campus recruitment solution, including online/offline campus presentation, employer branding, etc. In addition, it offers online survey and education services. The company was formerly known as Wise Talent Information Technology Co., Ltd and changed its name to Tongdao Liepin Group in July 2020. Tongdao Liepin Group was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China.
Full TGDLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.